Exelixis Inc. buy melinda
Start price
14.03.16
/
50%
€3.66
Target price
19.05.16
€5.41
Performance (%)
31.15%
End price
19.05.16
€4.80
Summary
This prediction ended on 19.05.16 with a price of €4.80. With a performance of 31.15% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Exelixis Inc. | 10.540% | 10.540% | 22.910% | 166.370% |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% | 113.046% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% | 47.267% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% | 68.687% |
Comments by melinda for this prediction
In the thread Exelixis Inc. diskutieren
métastase rénale
cancer